The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Markiewicz, M. A.
Right arrow Articles by Shaw, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Markiewicz, M. A.
Right arrow Articles by Shaw, A. S.
The Journal of Immunology, 2005, 175: 2825-2833.
Copyright © 2005 by The American Association of Immunologists

Costimulation through NKG2D Enhances Murine CD8+ CTL Function: Similarities and Differences between NKG2D and CD28 Costimulation1

Mary A. Markiewicz*, Leonidas N. Carayannopoulos{dagger}, Olga V. Naidenko*, Ken Matsui*, W. Richard Burack*, Erica L. Wise*, Daved H. Fremont*, Paul M. Allen*, Wayne M. Yokoyama{ddagger}, Marco Colonna* and Andrey S. Shaw2,*

* Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110; {dagger} Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO 63110; and {ddagger} Howard Hughes Medical Institute, Rheumatology Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110

Multiple studies have demonstrated that the NK cell activating receptor NKG2D can function as a costimulatory receptor for both mouse and human CD8+ T cells. However, it has recently been suggested that stimulation through NKG2D is insufficient for costimulation of CD8+ T cells. To aid in the delineation of NKG2D function in CTL responses, we investigated whether stimulation of NKG2D by the natural ligand RAE1{epsilon} was able to costimulate effector functions of a murine CTL line generated from DUC18 TCR transgenic mice. We found that NKG2D was able to costimulate DUC CTL responses and did so in a manner similar to CD28 costimulation. The T cells exhibited increased proliferation, IFN-{gamma} release, and cytotoxicity when presented antigenic peptide by P815 cells expressing RAE1{epsilon} or B7-1 compared with untransfected P815. In addition, both RAE1{epsilon} and B7-1 enhanced Ag-independent IFN-{gamma} secretion in response to IL-12 and IL-18 by DUC CTL. However, only costimulation through CD28 allowed for DUC CTL survival upon secondary stimulation, whereas ligation of NKG2D, but not CD28, induced DUC CTL to form an immune synapse with target cells in the absence of TCR stimulation. Understanding the outcomes of these differences may allow for a better understanding of T cell costimulation in general.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. M. Beal, N. Anikeeva, R. Varma, T. O. Cameron, P. J. Norris, M. L. Dustin, and Y. Sykulev
Protein Kinase C{theta} Regulates Stability of the Peripheral Adhesion Ring Junction and Contributes to the Sensitivity of Target Cell Lysis by CTL
J. Immunol., October 1, 2008; 181(7): 4815 - 4824.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
W. Cao, X. Xi, Z. Wang, L. Dong, Z. Hao, L. Cui, C. Ma, and W. He
Four novel ULBP splice variants are ligands for human NKG2D
Int. Immunol., August 1, 2008; 20(8): 981 - 991.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Iannello, O. Debbeche, S. Samarani, and A. Ahmad
Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS
J. Leukoc. Biol., July 1, 2008; 84(1): 1 - 26.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. B. Walsh, L. L. Lanier, and T. E. Lane
NKG2D Receptor Signaling Enhances Cytolytic Activity by Virus-Specific CD8+ T Cells: Evidence for a Protective Role in Virus-Induced Encephalitis
J. Virol., March 15, 2008; 82(6): 3031 - 3044.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. Giurisato, M. Cella, T. Takai, T. Kurosaki, Y. Feng, G. D. Longmore, M. Colonna, and A. S. Shaw
Phosphatidylinositol 3-Kinase Activation Is Required To Form the NKG2D Immunological Synapse
Mol. Cell. Biol., December 15, 2007; 27(24): 8583 - 8599.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. K. Choi, Y. H. Kim, W. J. Kang, S. K. Lee, K. H. Kim, S. M. Shin, W. M. Yokoyama, T. Y. Kim, and B. S. Kwon
Mechanisms Involved in Synergistic Anticancer Immunity of Anti-4-1BB and Anti-CD4 Therapy
Cancer Res., September 15, 2007; 67(18): 8891 - 8899.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Cao, X. Xi, Z. Hao, W. Li, Y. Kong, L. Cui, C. Ma, D. Ba, and W. He
RAET1E2, a Soluble Isoform of the UL16-binding Protein RAET1E Produced by Tumor Cells, Inhibits NKG2D-mediated NK Cytotoxicity
J. Biol. Chem., June 29, 2007; 282(26): 18922 - 18928.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Barber, T. Zhang, L. R. DeMars, J. Conejo-Garcia, K. F. Roby, and C. L. Sentman
Chimeric NKG2D Receptor-Bearing T Cells as Immunotherapy for Ovarian Cancer
Cancer Res., May 15, 2007; 67(10): 5003 - 5008.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Chen, P. P. Trivedi, B. Ge, K. Krzewski, and J. L. Strominger
Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity
PNAS, April 10, 2007; 104(15): 6329 - 6334.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Roda-Navarro, M. Vales-Gomez, S. E. Chisholm, and H. T. Reyburn
Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function
PNAS, July 25, 2006; 103(30): 11258 - 11263.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. D. Bui, L. N. Carayannopoulos, L. L. Lanier, W. M. Yokoyama, and R. D. Schreiber
IFN-Dependent Down-Regulation of the NKG2D Ligand H60 on Tumors
J. Immunol., January 15, 2006; 176(2): 905 - 913.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.